Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, September 18, 2014
 
Register | Sign in
Home Page>Products
  Product News
Bosch Showcases Secondary Packaging Solutions
Friday, August 29, 2014
Strengthening position as single-source solutions provider.

Measure Both Elastic and Viscous Properties with AFM
Friday, August 29, 2014
Asylum Research’s exclusive AM-FM viscoelastic mapping mode.

Impressive Separation of a Fusion Protein
Friday, August 29, 2014
Separation of protein by high-resolution hydrophobic interaction chromatography method.

Onxeo Strengthens Beleodaq® Patent Protection in the U.S. Until 2027
Friday, August 29, 2014
U.S. Patent will be granted on September 16th 2014.

Lightweight Electronic Pipette Offers Enhanced Ease of Use
Thursday, August 28, 2014
Jump from minimum to maximum volume within a second.

Precise Flow Measurement at Elevated Temperatures
Thursday, August 28, 2014
High temperature Atrato ultrasonic flowmeter from Titan Enterprises.

Swift Analytical to Exhibit the DeNovix DS-11 during the ELRIG Drug Discovery 2014 Meeting
Thursday, August 28, 2014
Swift Analytical will be exhibiting the ground breaking DeNovix DS-11 microvolume spectrophotometer during the ELRIG Drug Discovery Meeting in the Innovation Zone, booth number IZ16.

Innova Biosciences Introduces InnovaGOLD Nanoparticles
Thursday, August 28, 2014
New ultra-high quality gold nanoparticles simplify assay development and improve the sensitivity of immunoassays.

Elegant Fraction Collection Storage Solution
Wednesday, August 27, 2014
Company offers a free pack of 50 cap mats with each order until 30th November 2014.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 10491
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv